Novonesis Delivers Strong Full-year Results And Expects Continued Growth In 2025
26 February 2025, Denmark: In the 2024 financial year, Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin at 36.1%.
Read MoreNovonesis covers the latest news, product launches, research breakthroughs, strategic partnerships, sustainability initiatives, business developments, and biosolutions innovations from one of the world’s leading biosolutions companies. Formed through the merger of Novozymes and Chr. Hansen in 2024, Novonesis develops microbial and enzyme-based solutions for agriculture, food, animal health, bioenergy, and industrial applications. Read about agricultural biologicals, biofertilizers, inoculants, biocontrol, plant health, nitrogen fixation, microbial technologies, regenerative agriculture, sustainable crop production, and biosolutions for farming. Stay updated on Novonesis partnerships, commercialization agreements, product innovations, and technologies helping growers improve productivity, resilience, and sustainability.
26 February 2025, Denmark: In the 2024 financial year, Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin at 36.1%.
Read More16 September 2024, New Delhi: Krishak Bharati Cooperative Limited (KRIBHCO) and Novonesis signed an MoU announcing a long-term commitment to explore collaboration
Read More